Abbott will withdraw the diet drug Meridia pursuant to the FDA’s request because of “clinical trial data indicating an increased risk of heart attack and stroke.”
The crazy thing with Meridia is that it has been on the market for 13 years. Meridia also was not selling very well, which helped grease the wheels for this withdraw. Meridia might have helped some people lose some weight. But at some point, unlike Lipitor, which was the subject of the last post, the benefits of the drug were outweighed by the risk of heart attack and/or stroke. According to at least one study, people taking Meridia had a 28 percent higher risk for non-fatal heart attack and a 36 percent raised risk for non-fatal stroke, compared with those taking a placebo,
There is a great demand for a good diet drug. If anyone can make one that really works that has limited side effects, someone will make a fortune. But it will not be Abbott with Meridia.